ZA979862B - Progesterone for treating or reducing ischemia. - Google Patents

Progesterone for treating or reducing ischemia.

Info

Publication number
ZA979862B
ZA979862B ZA9709862A ZA979862A ZA979862B ZA 979862 B ZA979862 B ZA 979862B ZA 9709862 A ZA9709862 A ZA 9709862A ZA 979862 A ZA979862 A ZA 979862A ZA 979862 B ZA979862 B ZA 979862B
Authority
ZA
South Africa
Prior art keywords
progesterone
treating
reducing ischemia
ischemia
reducing
Prior art date
Application number
ZA9709862A
Other languages
English (en)
Inventor
Howard L Levine
William J Bologna
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA979862(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of ZA979862B publication Critical patent/ZA979862B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9709862A 1996-11-04 1997-11-03 Progesterone for treating or reducing ischemia. ZA979862B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/743,153 US5985861A (en) 1996-11-04 1996-11-04 Progesterone for treating or reducing ischemia

Publications (1)

Publication Number Publication Date
ZA979862B true ZA979862B (en) 1998-05-25

Family

ID=24987712

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709862A ZA979862B (en) 1996-11-04 1997-11-03 Progesterone for treating or reducing ischemia.

Country Status (27)

Country Link
US (2) US5985861A (hu)
EP (1) EP0956023B1 (hu)
KR (1) KR100434623B1 (hu)
CN (1) CN100341512C (hu)
AR (1) AR009407A1 (hu)
AT (1) ATE321558T1 (hu)
AU (1) AU715740C (hu)
BR (1) BR9710918A (hu)
CA (1) CA2270565C (hu)
DE (1) DE69735598T2 (hu)
DK (1) DK0956023T3 (hu)
ES (1) ES2262196T3 (hu)
GE (1) GEP20022630B (hu)
HK (1) HK1020534A1 (hu)
HU (1) HUP9904045A3 (hu)
IL (1) IL127455A (hu)
LV (1) LV12342B (hu)
MA (1) MA24391A1 (hu)
MY (1) MY121627A (hu)
NO (1) NO324278B1 (hu)
NZ (1) NZ335306A (hu)
PE (1) PE9899A1 (hu)
PT (1) PT956023E (hu)
RO (1) RO120607B1 (hu)
UA (1) UA66772C2 (hu)
WO (1) WO1998019681A1 (hu)
ZA (1) ZA979862B (hu)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
US6602487B1 (en) 1997-02-26 2003-08-05 Dimera Incorporated Methods and tests for producing and for inhibiting coronary artery vasospasms
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
US7833545B2 (en) 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
DE102005027004B4 (de) * 2005-06-10 2020-03-19 Continental Automotive Gmbh Scheibenwaschvorrichtung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
WO2009099586A2 (en) 2008-02-04 2009-08-13 Duramed Pharmaceuticals, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
JP6285866B2 (ja) 2011-11-23 2018-02-28 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
MX2016013693A (es) 2014-07-29 2017-10-31 Therapeuticsmd Inc Crema transdermica.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11512107B2 (en) 2018-09-07 2022-11-29 Trustees Of Dartmouth College Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
CA3109978A1 (en) * 2018-09-07 2020-03-12 Trustees Of Dartmouth College C19 scaffolds and steroids and methods of use and manufacture thereof
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124906A1 (ru) * 1982-05-25 1984-11-23 Ивановский государственный медицинский институт им.А.С.Бубнова Способ коррекции ишемических повреждений консервированной донорской почки
EP0163696B1 (en) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Use of a bioadhesive
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof

Also Published As

Publication number Publication date
PE9899A1 (es) 1999-02-08
AU715740C (en) 2004-04-29
AU715740B2 (en) 2000-02-10
HK1020534A1 (en) 2000-05-12
IL127455A0 (en) 1999-10-28
DE69735598T2 (de) 2006-12-28
EP0956023B1 (en) 2006-03-29
KR20000053056A (ko) 2000-08-25
LV12342B (en) 2000-01-20
BR9710918A (pt) 2000-01-11
ATE321558T1 (de) 2006-04-15
AU5180198A (en) 1998-05-29
NO992140D0 (no) 1999-05-03
CA2270565C (en) 2007-02-20
CA2270565A1 (en) 1998-05-14
US6054447A (en) 2000-04-25
HUP9904045A2 (hu) 2000-04-28
US5985861A (en) 1999-11-16
ES2262196T3 (es) 2006-11-16
PT956023E (pt) 2006-08-31
DK0956023T3 (da) 2006-08-07
NZ335306A (en) 2000-12-22
GEP20022630B (en) 2002-02-25
MY121627A (en) 2006-02-28
HUP9904045A3 (en) 2000-11-28
CN1235549A (zh) 1999-11-17
RO120607B1 (ro) 2006-05-30
NO324278B1 (no) 2007-09-17
DE69735598D1 (de) 2006-05-18
NO992140L (no) 1999-05-04
LV12342A (lv) 1999-09-20
UA66772C2 (uk) 2004-06-15
MA24391A1 (fr) 1998-07-01
EP0956023A1 (en) 1999-11-17
WO1998019681A1 (en) 1998-05-14
KR100434623B1 (ko) 2004-06-05
IL127455A (en) 2005-03-20
AR009407A1 (es) 2000-04-12
CN100341512C (zh) 2007-10-10

Similar Documents

Publication Publication Date Title
ZA979862B (en) Progesterone for treating or reducing ischemia.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
HUP9903333A3 (en) King-pin adjuster
SG65015A1 (en) Substrate treatment system
ZA9711216B (en) Fastening arrangement for absorbent garments.
ZA978178B (en) Composition.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
AU6200999A (en) Treatment for fabrics
ZA97631B (en) Migraine treatment.
AU6268899A (en) Systems and methods for treating ischemia
ZA977206B (en) Arylalkanoylpyridazines.
ZA975261B (en) Composition.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA973707B (en) Method for treating inflammation.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA976056B (en) Block former.
ZA9711567B (en) Compounds.
ZA979290B (en) Fastening means for an absorbent garment.
ZA975861B (en) Bromotiacumicin compounds.
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
ZA979151B (en) Pyrazolinones for treating impaired potency.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA976022B (en) Cycloalkano-pyridines.
ZA971466B (en) Endothelin-receptor-antagonists.